Alimera Sciences Stock (NASDAQ: ALIM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 74.801K |
Day Range | - - - |
52 Wk Range | 1.560 - 4.380 |
Market Cap | $190.644M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 0.55% |
Days to Cover | 1.71 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alimera Sciences (NASDAQ: ALIM) through any online brokerage.
Other companies in Alimera Sciences’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Jaguar Health (NASDAQ:JAGX), Rani Therapeutics Hldgs (NASDAQ:RANI) and Aquestive Therapeutics (NASDAQ:AQST).
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by Maxim Group on Monday, March 25, 2024. The analyst firm set a price target for 10.00 expecting ALIM to rise to within 12 months (a possible 174.73% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Alimera Sciences (NASDAQ: ALIM) is $3.64 last updated May 7, 2024 at 9:27 AM EDT.
There are no upcoming dividends for Alimera Sciences.
Alimera Sciences’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Alimera Sciences.
Alimera Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.